trending Market Intelligence /marketintelligence/en/news-insights/trending/Nc--9oOYPsOIPs4ZAluiRA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Bausch seeks to redeem $1.24B of senior notes

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Bausch seeks to redeem $1.24B of senior notes

Bausch Health Companies Inc. issued a conditional redemption notice for $1.24 billion of its outstanding 5.875% senior notes due 2023.

The company will redeem the notes only if it generates gross proceeds of at least $2.50 billion from its offering of $1.25 billion each of its 5.000% notes due 2028 and 5.250% notes due 2030.

The offering is expected to close Dec. 30.

In addition to redeeming its 5.875% notes, Bausch intends to use the gross proceeds from the offering to pay the amounts it owes for the $1.21 billion settlement of a class-action lawsuit, which claimed that the company failed to warn investors amid a drastic drop in share price beginning in 2015.

Laval, Quebec-based Bausch develops and commercializes eye, skin and digestive system treatments.